Cardiac Ablation Market OverviewThe cardiac ablation market is set to grow at an impressive CAGR of approximately 13% over the forecast period, driven by a combination of clinical, technological, and ...

Catheter ablation significantly reduces cardiovascular risks and mortality in patients with both atrial fibrillation and obstructive sleep apnea. The study involved over 18,000 patients, showing a ...

Thermedical®, a developer of advanced thermal-ablation technologies, today announced that the first patient has been treated in a pivotal clinical study evaluating its Saline Enhanced Radiofrequency ...

A recent editorial article emphasized that the updated 2023 and 2024 guidelines for Atrial Fibrillation (AF) provide major ...

Doctors may soon be able to diagnose an elusive form of heart disease within seconds by using an AI model developed at ...

George Westerik recently became the first patient at London Health Sciences Centre (LHSC) to receive radiation therapy for a cardiac condition - a ...

Adagio Medical Holdings, Inc ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that Sean Salmon has been ...

Milestone Pharmaceuticals Inc.’s CARDAMYST nasal spray wins FDA approval for PSVT, but faces tough competition and market ...

First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed to rapidly ...

TN-401 was Well Tolerated at 3E13 vg/kg dose Robust Transduction and Demonstrated Increases in PKP2 Protein Levels in First Two Patients at Week ...

AI, machine learning, and cloud platforms are reshaping remote patient monitoring. These technologies support predictive ...

Patrick's scan showed "significant blockages" in his arteries, Murray said. He was at high risk for a dangerous cardiac event ...